Tag: Immunotherapy
High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy
Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade
Survival Up With Tebentafusp in Metastatic Uveal Melanoma
Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma
Many With Food Allergy Unaware of Oral Immunotherapy Option
Awareness disproportionately higher among wealthier, more highly educated respondents
COVID-19 Immune Response Appears Strong in Cancer Patients
Vast majority show seropositivity four months after the second COVID-19 vaccine dose
Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL
Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy
Hyperimmune Globulin Does Not Prevent Congenital CMV Infection
Cytomegalovirus hyperimmune globulin does not lower incidence of composite of congenital CMV infection, perinatal death in offspring
Immunomodulation With IVIG, Glucocorticoids Examined in MIS-C
Early outcomes of two large observational studies show mixed results for the efficacy of immunomodulation with IVIG, glucocorticoids, or both
VTE Risk High in Cancer Patients Receiving Immune Checkpoint Inhibitors
History of VTE predicts VTE occurrence; VTE occurrence linked to increased mortality
FDA Approves Immunotherapy for dMMR Endometrial Cancer
Jemperli approved for dMMR endometrial cancer that progressed after platinum-containing chemotherapy treatment
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days
